Use of Probiotics in Pediatrics: Rationale, Mechanisms of Action, and Practical Aspects
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The use of probiotics (ingested microbes that can modify intestinal microbial populations in a way that benefit the host) has moved from concept to actual demonstration of specific benefits by specific microorganisms for specific populations. It is increasingly clear that these benefits to the host are mostly mediated by the profound effect that intestinal microflora (microbiota) have on gut barrier function and host immune response. Intestinal bacteria are more numerous than the human cells of the host that harbors them. Despite having many potential pathogens in this microflora, humans do not routinely get infected. It is no coincidence that gut‐associated immune tissue constitutes approximately 80% of all immunologically active cells in the human host. The gut interacts with intestinal bacteria, both resident and ingested, to develop protective mechanisms (via improving gut barrier function and immune stimulation for defense) and appropriate, nonexaggerated responses (via immune modulation and immune tolerance) to support host health. The mechanisms of this interaction between host and bacteria are increasingly being unraveled and in great part explain the clinical benefits that have been reported with specific probiotic bacteria by enhancing host defense mechanisms (such as for treatment and prevention of viral diarrhea and reducing risk of necrotizing enterocolitis), mitigating antibiotic‐associated diarrhea, and modulating host immune response (such as in allergic disease).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lin, H.-C., Su, B.-H., Chen, A.-C., Lin, T.-W., Tsai, C.-H., Yeh, T.-F., & Oh, W. (2005) · Pediatrics · doi:10.1542/peds.2004-1463 · Cited by 660
Lactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599
Oral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight Neonates
Bin-Nun, A., Bromiker, R., Wilschanski, M., Kaplan, M., Rudensky, B., Caplan, M., & Hammerman, C. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.03.054 · Cited by 590
Weizman, Z., Asli, G., & Alsheikh, A. (2005) · Pediatrics · doi:10.1542/peds.2004-1815 · Cited by 548
Yoshioka, H., Iseki, K.-I., & Fujita, K. (1983) · PEDIATRICS · doi:10.1542/peds.72.3.317 · Cited by 516 · cited 2×
“Formula-fed infants, on the other hand, tend to have a flora that is more complex, consisting mostly of coliforms and Bacteroides, with significantly lower prevalence of Bifidobacteria.15,16 After weaning, the microflora of children begins to resemble that of adults, with Bacteroides, Veillonella, and Fusobacterium on…”
BackgroundGupta, P., Andrew, H., Kirschner, B. S., & Guandalini, S. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200010000-00024 · Cited by 429
Schiffrin, E., Brassart, D., Servin, A., Rochat, F., & Donnet-Hughes, A. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.2.515s · Cited by 354 · cited 1×
“These same probiotics, as well as B lactis, have been shown to increase phagocytic activity against E coli species, as well as enhance natural killer cell activity.(64,65) Among the more consistently found effects of specific Bifidobacteria and Lactobacilli in pediatric populations is the effect on humoral immunity, p…”
BackgroundFermented Foods—A World Perspective
Campbell-Platt, G. (1994) · Food Research International · doi:10.1016/0963-9969(94)90093-0 · Cited by 335 · cited 1×
“Today, foods and beverages containing lactic-acid-producing bacteria (LAB) constitute up to 40% of the food supply worldwide.(10) LAB, particularly members of the genus Lactobacilli, Bifidobacteria, and Streptococcus, are the most widely used in the food supply, and they are rarely associated with infections or negati…”
BackgroundTwo cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome
Kunz, A. N., Noel, J. M., & Fairchok, M. P. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200404000-00017 · Cited by 319 · cited 1×
“Case reports of L rhamnosus (GG) infections possibly associated with probiotic consumption, in immunocompromised patients have been even less common.(109,110) The mechanisms for these infections and route of contamination are unclear.”
BackgroundLinskens, R. K., Huijsdens, X. W., Savelkoul, P. H. M., Vandenbroucke-Grauls, C. M. J. E., & Meuwissen, S. G. M. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201753265082 · Cited by 233
Cited by
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
O’Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., & Cryan, J. F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.027 · Cited by 2,012
ESPGHAN Committee on Nutrition:, Braegger, C., Chmielewska, A., Decsi, T., Kolacek, S., Mihatsch, W., Moreno, L., Pieścik, M., Puntis, J., Shamir, R., et al. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181fb9e80 · Cited by 442
Importance of probiotics in the prevention and treatment of colorectal cancer
Eslami, M., Yousefi, B., Kokhaei, P., Hemati, M., Nejad, Z. R., Arabkari, V., & Namdar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28473 · Cited by 285
Hojsak, I., Snovak, N., Abdović, S., Szajewska, H., Mišak, Z., & Kolaček, S. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.09.008 · Cited by 264
Unraveling Mechanisms of Action of Probiotics
Sherman, P. M., Ossa, J. C., & Johnson‐Henry, K. (2009) · Nutrition in Clinical Practice · doi:10.1177/0884533608329231 · Cited by 230
Metadata
- Authors
- Saavedra, J. M.
- Venue
- Nutrition in Clinical Practice
- Publisher
- Wiley
- Published
- 2007-06
- Volume
- 22
- Issue
- 3
- Pages
- 351-365
- ISSN
- 0884-5336 (ISSN-L)
- 1941-2452
- OpenAlex
- W2014325789
- Cited by
- 126
- References
- 11
- FWCI
- 16.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Probiotics in Pediatrics: Rationale, Mechanisms of Action, and Practical Aspects. https://app.cochat.ai/papers/10.1177/0115426507022003351
- The paper
- Saavedra, J. M. (2007). Use of Probiotics in Pediatrics: Rationale, Mechanisms of Action, and Practical Aspects. Nutrition in Clinical Practice. https://doi.org/10.1177/0115426507022003351
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.